(HealthDay)—For patients with melanoma arising in head and neck subsites (HNM), there is no association between sentinel lymph node biopsy (SLNB) and disease-specific survival (DSS), according to research published in the ...
Dec 21, 2014
0
0
Researchers at the UT Research Institute MIRA have developed a new method for tracing the sentinel lymph node, the node by which you can tell whether a patient's cancer has spread. Martijn Visscher demonstrated that you can ...
Aug 29, 2014
0
0
The use of sentinel lymph node biopsy (SLNB) to stage early breast cancer increased in both black and white women from 2002 to 2007, but the rates remained lower in black than white patients, a disparity that contributed ...
Jun 18, 2014
0
0
Startling data from an international multi-center trial provide growing evidence that sentinel node imaging is more effectively accomplished with hybrid functional imaging with single photon emission computed tomography and ...
Jun 9, 2014
0
0
In order to determine the best treatment for patients affected by cancer, it is crucial for physicians to identify how the disease is spreading via lymph nodes in the body—a process known as metastasis. Progression of the ...
Jun 4, 2014
0
0
A team of researchers from Women & Infants Hospital of Rhode Island commanded a national stage to present the results of a study evaluating the use of sentinel lymph node dissection in women with vulvar malignancies, and ...
Mar 26, 2014
0
0
(HealthDay)—Biopsies of so-called "sentinel" lymph nodes under the arms should become more widespread among breast cancer patients, according to updated guidelines from the American Society of Clinical Oncology (ASCO).
Mar 24, 2014
0
0
Research at UCLA on a technique for detecting the earliest spread of melanoma, the deadliest form of skin cancer, has confirmed that the procedure significantly prolongs patients' survival rates compared with traditional ...
Mar 4, 2014
0
0
Cancer cell spread to the sentinel node—the lymph node to which cancer cells are most likely to spread from a primary tumor—is a risk factor for melanoma death. According to a study published in this week's PLOS Medicine ...
Feb 18, 2014
0
0
(Medical Xpress)—Melanoma patients who had a specific subtype of immune cells called CD30-positive T cells in the lymph nodes closest to their tumors were more likely to have their disease progress within five years, according ...
Jan 6, 2014
0
0
